GSK pharma Gets CDSCO Panel Nod To study Respiratory Syncytial Virus vaccine RSVPreF3 OA Dr. Divya Colin10 Jun 2024 6:00 PM ISTNew Delhi: Advising to include clinical trial sites from various states in the southern part of India, the Subject Expert Committee (SEC) functional...
USFDA approves expanded age indication for GSK RSV vaccine Arexvy for adults aged 50-59 at increased risk Ruchika Sharma9 Jun 2024 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine,...
GSK acquires Elsie Biotechnologies for up to USD 50 million Ruchika Sharma7 Jun 2024 4:22 PM ISTLondon: GSK plc has announced that it has acquired Elsie Biotechnologies, a San Diego-based private biotechnology company working on unlocking the...
GSK disagrees with ruling by Delaware State Court on ranitidine litigation, to seek appeal Ruchika Sharma3 Jun 2024 2:41 PM ISTLondon: GSK plc has announced that it disagrees with the ruling by the Delaware State Court and will immediately seek an appeal. The decision by...
Zantac not a cause of woman's cancer, says jury Ruchika Sharma24 May 2024 3:34 PM ISTChicago: A jury in Chicago delivered a verdict on Thursday, dismissing the claim of an Illinois woman who alleged that the discontinued...
GSK raises USD 1.5 billion from sale of remaining Haleon stake Ruchika Sharma19 May 2024 11:30 AM ISTGSK sold around 385 million shares at 324 pence each, amounting to a 4.2 per cent stake in Haleon.
India becoming attractive for clinical trials: Pharma industry leaders Ruchika Sharma29 April 2024 2:33 PM ISTNew Delhi: Experts from the pharmaceutical sector have noted that over the last decade, clinical trials in India have undergone significant...
Eminent diabetologist Padmashri Dr V Mohan rebukes multivitamin advertisement Roshni Dhar26 April 2024 5:00 PM ISTEminent diabetologist Padmashri Dr V Mohan recently took to social media platform X to rebuke a multivitamin advertisement, asserting that "there's...
GSK application for expanded indication of Jemperli plus chemotherapy accepted by USFDA for priority review Ruchika Sharma25 April 2024 12:40 PM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for...
There is nothing called multivitamin deficiency: Leading Diabetologist slams Haleon's Centrum Advertisement Farhat Nasim25 April 2024 11:50 AM ISTNew Delhi: Eminent diabetologist Padmashri Dr V Mohan recently took to social media platform X to rebuke a multivitamin advertisement, asserting that...
GSK Gets CDSCO Panel Nod to Study antimalarial drug Tafenoquine Dr. Divya Colin24 April 2024 6:00 PM ISTNew Delhi: The pharmaceutical major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
USFDA accepts for review GSK 5-in-1 meningococcal ABCWY vaccine candidate Ruchika Sharma17 April 2024 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for...
